Evidence map›Paper›PMID 42621597›Full record

ArticleInternational journal of preventive medicine2026

The Factors Affecting the Screening of New Colorectal Cancer Cases Between 2020 and 2022 in Isfahan Province.

Elaheh Ebrahimi, Razieh Hassannejad, Masood Shekarchizadeh, Jamshid Najafan, Zamane Vafaei, Samaneh Mostafavi, Fateme Nouri, Reihaneh Zavar, Ali Darakhshandeh, Mohammadreza Khosravifarsani and 8 more

Abstract read
In one paragraph

Article in International journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Elaheh EbrahimiDepartment of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Razieh HassannejadPediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Masood ShekarchizadehIsfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Jamshid NajafanHypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Zamane VafaeiIsfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Samaneh MostafaviInterventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Fateme NouriInterventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Reihaneh ZavarDepartment of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Ali DarakhshandehDepartment of Medical Oncology-Hematology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammadreza KhosravifarsaniCancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Farzaneh AshrafCardio-Oncolog Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran.
Mehran SharifiDepartment of Internal Medicine, School of Medicine Cancer Prevention Research Center Seyyed AlShohada Hospital Isfahan University of Medical Sciences, Isfahan, Iran.
Ali AkhavanDepartment of Radio-Oncology, Seyed-Al-Shohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Nadia NajafizadehDepartment of Radiation-Oncology, Isfahan University of Medical Sciences, Isfahan, Iran.
Alireza SadeghiDepartment of Internal Medicine, Oncology and Hematology Section, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Maryam MirporianOncology and Hematology Section, Seyed-Al-Shohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Masoumeh SadeghiCardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Nizal SarrafzadeganIsfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colorectal cancer (CRC) is one of the most common neoplasms in Iran. The objectives of this study were to determine the factors affecting the screening of new colon cancer cases in Isfahan province. Methods: This present study is a cross-sectional study that was conducted within the framework of the Cardio Vascular Events in Breast and Colorectal Cancers (CIBC) study. CIBC is a multicenter prospective cohort study of newly diagnosed BC and CRC patients that has been started in Iran since 2019 and will be continued until 2024. In this study, all patients who were diagnosed with CRC were considered between January 2020 and January 2022. Information was collected through a questionnaire. Results: In total, 78 cases in our study had colon cancer, and 69 had rectal cancer. The majority of patients in our study were between ages of 45-75 (74.4%), married (97%), educated (77%), urban-based (89.4%), nonsmoker (79.5%) and nondrinker (97%), had insurance coverage (96.3%) and had normal levels of depression (52.5%), anxiety (54.4%) and stress (77.5%). Higher age ( Conclusions: Understanding the importance of CRC screening is critical to improve population health. According to the results, higher age, higher anxiety, and a history of colorectal surgery were the main factors affecting participation in the CRC screening programs.

Indexed as

Colorectal cancerIranscreening

Identifiers

PMID42621597
PMCPMC13489567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.